Wall Street Associates’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding NPTN
OMC
AIC
HFM
NC
MCM
GT
RA
Wall Street Associates's NPTN Position: Q4 2016 in Review
Wall Street Associates reduced its NEOPHOTONICS CORP (NPTN) stake by 37% in Q4 2016, selling an estimated $873K and leaving 112,000 shares worth $1.21M. The position accounts for 0.8% of the portfolio, ranked #41.
Wall Street Associates first reported a position in NPTN in Q4 2015 and has held it in 5 quarters since. The position peaked at $2.9M in Q3 2016. 127 funds tracked by Wall St. Rank hold NPTN as of Q4 2016.
- Wall Street Associates held 112,000 shares of NEOPHOTONICS CORP worth $1.21M as of Q4 2016.
- Wall Street Associates sold 65,500 NEOPHOTONICS CORP shares in Q4 2016, an estimated $873K.
- NEOPHOTONICS CORP made up 0.8% of Wall Street Associates's portfolio in Q4 2016, its #41 holding.
- Wall Street Associates first reported a position in NEOPHOTONICS CORP in Q4 2015 and has held it in 5 quarters since.
- Wall Street Associates's NEOPHOTONICS CORP position peaked at $2.9M in Q3 2016.
- 127 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2016.
Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.